CHOC’s hydrocephalus research laboratory team receives grant that could lead to improvements in care for a debilitating and complex disease.
At the annual symposium, hundreds will gather to share about advances in rare disease research and a unifying theme: hope.
Physicians at CHOC lead a new study to improve survival rates of children with pediatric acute lymphoblastic leukemia (ALL).
The upcoming webinar is open to the public, and will share the latest developments in the battle against rare mtARS mitochondrial diseases.
A CHOC AYA oncology patient uses her experience to give back to others by participating in ongoing cancer research and clinical trials.
CHOC selects newborn patient as candidate for international study to test the efficacy of Lacosamide in the treatment of neonatal seizures.